MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.thromres.2020.08.041

Медицинская библиотека · Thrombosis research · 2020

Association of fractalkine with functional severity of heart failure and impact on clopidogrel efficacy in patients with ischemic heart disease.

Marcano Ana Lucrecia, Lugo Leslie Marisol, Besteiro Adrián, Gomez-Lara Josep, Roura Gerard, Fuentes Lara, Gracida Montserrat, Teruel Luis, Romaguera Rafael, Sosa Silvia Gabriela, Cequier Ángel, Gómez-Hospital Joan A, Comin-Colet Josep, Ferreiro José Luis

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

INTRODUCTION

Patients with heart failure (HF) display elevated levels of soluble fractalkine, a chemokine involved in inflammation processes, atherosclerosis and platelet activation. Further, fractalkine has been associated with reduced pharmacodynamic (PD) responsiveness to clopidogrel. The aim of this study was to investigate the association of fractalkine with the severity of HF and its impact on platelet activation and clopidogrel response in patients with coronary artery disease (CAD) with and without HF.

MATERIALS AND

METHODS

This prospective PD study included 116 stable CAD patients on DAPT with aspirin and clopidogrel. Subjects were classified in two groups: patients with HF and reduced (<40%) left ventricular ejection fraction (HFrEF group, n = 56) and patients without HF (no HF group, n = 60). Clinical severity of HF was graded according to NYHA classification. Platelet function assays included vasodilator-stimulated phosphoprotein assay, multiple electrode aggregometry and light transmittance aggregometry. Fractalkine and P-selectin concentrations were determined by ELISA.

RESULTS

Fractalkine levels progressively increased with the severity of the disease in the HFrEF group (NYHA I: 471.2 ± 52.4 pg/ml, NYHA II: 500.5 ± 38.4 pg/ml, NYHA III: 638.9 ± 54.3 pg/ml, p for linear trend 0.023). Numerically higher concentrations of fractalkine were observed in the HFrEF group compared to the no HF group with borderline significance (p = 0.052). No significant differences in clopidogrel-induced platelet inhibition according to fractalkine values were observed in any of the groups.

CONCLUSIONS

Fractalkine levels were increased in patients with HFrEF and positively associated with the functional severity of the disease. No evident impact of fractalkine on clopidogrel PD efficacy was found.

Для цитирования: Marcano Ana Lucrecia, Lugo Leslie Marisol, Besteiro Adrián, Gomez-Lara Josep, Roura Gerard, Fuentes Lara, Gracida Montserrat, Teruel Luis, Romaguera Rafael, Sosa Silvia Gabriela, Cequier Ángel, Gómez-Hospital Joan A, Comin-Colet Josep, Ferreiro José Luis. Association of fractalkine with functional severity of heart failure and impact on clopidogrel efficacy in patients with ischemic heart disease.. Thrombosis research. 2020. DOI: 10.1016/j.thromres.2020.08.041.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.